Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Dwarfism

• Vosoritide for Short Stature in Turner Syndrome
• A Trial of YPEG-rhGH in Children With Short Stature
• Vosoritide for Selected Genetic Causes of Short Stature
• Height Versus Height and Weight Based Spinal Bupivacaine on Maternal Haemodynamics for Elective Cesarean in Short Stature Patients
• A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day
• A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation
• Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency
• A Study of PEG-somatropin in the Treatment of Children With Idiopathic Short Stature
• Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.
• Individualizing Dose of Growth Hormone to Maintain Normal Growth Velocity After Fulfilled Catch up Growth in Children
• Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial
• IGF-1 Treatment for Individuals With Short Stature Due to PAPP-A2 Deficiency
• Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole
• The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature
• Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome
• Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission
• Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA)
• Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature
• Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature
• A Phase 3 Study to Evaluate the Safety and Efficacy of Saizen® in Children With Idiopathic Short Stature (ISS)
• Safety and Efficacy of Long-term Somatropin Treatment in Children
• Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF)
• Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers
• Increlex Treatment of Children With Chronic Liver Disease and Short Stature
• Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature
• Short Stature Related Distress
• Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children
• Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen®
• A Multicentre, Randomised, Open-label, Controlled Study to Evaluate the Effects of Saizen® on Cardiac Function in Growth Hormone Deficient(GHD) Subjects During the Transition Phase From Childhood to Adulthood
• Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated at Least 3 Years or Until Near Final Height, When Applicable, in Comparison With a Historic Cohort of N
• Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing
• Observational Study of Somatropin Treatment in Children
• Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years
• An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)
• A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height
• An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)
• Drug Use Investigation of Somatropin for GHD-ADULTS.
• rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency
• Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)
• Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin
• rhGH Therapy on Hepatic Drug Metabolism
• Biochemical Markers of Growth Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
• D3-GHR Polymorphism and Turner Syndrome
• Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
• Growth Hormone and Endothelial Function in Children
• Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short Stature
• Effects of Growth Hormone in Chronically Ill Children
• Effect of Growth Hormone in Children With Growth Hormone Deficiency
• Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq
• Amendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopathic Short Stature
• Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary
• Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy
• Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 Deficiency
• Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature
• Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children
• Role of Nutrition and Hormones in Boys With Disordered Growth
• The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome
• Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature